That is the drugs intended future: obesity as an entry point, organ comorbidities as label-expansion targets
Additionally, I extend our appreciation to King Abdulaziz University for providing valuable support and facilitating access to essential research materials through the electronic library portal offered by Clarivate Analytics
2007 Oct;61(10):1777-8 )
Matteau E, Dupre N, Langlois M, Jean L, Thivierge S, Provencher P, et al
Common : Nausea (up to 44%), vomiting, diarrhea, constipation Less common : Fatigue, dyspepsia, bloating, dizziness Rare : Cholelithiasis, acute pancreatitis Serious : Risk of thyroid tumors (animal data), kidney impairment due to dehydration Proper storage is critical to maintaining the products efficacy
One of the largest concerns with Tylenol is the potential for toxicity with excessive doses